ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liraglutide Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-29O4198
Home | Market Reports | Health| Health Foundations & Medical Research
Global Liraglutide Market Research Report 2021
BUY CHAPTERS

Global Liraglutide Market Research Report 2024

Code: QYRE-Auto-29O4198
Report
January 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm

Liraglutide Market

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
The global Liraglutide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Liraglutide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Liraglutide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide and AmbioPharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Liraglutide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liraglutide.

Report Scope

The Liraglutide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liraglutide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liraglutide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Liraglutide Market Report

Report Metric Details
Report Name Liraglutide Market
Segment by Type
  • Pills
  • Liquid
Segment by Application
  • Hospital
  • Drug Store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Liraglutide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Liraglutide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Liraglutide Market report?

Ans: The main players in the Liraglutide Market are HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm

What are the Application segmentation covered in the Liraglutide Market report?

Ans: The Applications covered in the Liraglutide Market report are Hospital, Drug Store

What are the Type segmentation covered in the Liraglutide Market report?

Ans: The Types covered in the Liraglutide Market report are Pills, Liquid

1 Liraglutide Market Overview
1.1 Product Overview and Scope of Liraglutide
1.2 Liraglutide Segment by Type
1.2.1 Global Liraglutide Market Value Comparison by Type (2024-2030)
1.2.2 Pills
1.2.3 Liquid
1.3 Liraglutide Segment by Application
1.3.1 Global Liraglutide Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Liraglutide Market Size Estimates and Forecasts
1.4.1 Global Liraglutide Revenue 2019-2030
1.4.2 Global Liraglutide Sales 2019-2030
1.4.3 Global Liraglutide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Liraglutide Market Competition by Manufacturers
2.1 Global Liraglutide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Liraglutide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Liraglutide Average Price by Manufacturers (2019-2024)
2.4 Global Liraglutide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liraglutide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liraglutide, Product Type & Application
2.7 Liraglutide Market Competitive Situation and Trends
2.7.1 Liraglutide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Liraglutide Players Market Share by Revenue
2.7.3 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Liraglutide Retrospective Market Scenario by Region
3.1 Global Liraglutide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Liraglutide Global Liraglutide Sales by Region: 2019-2030
3.2.1 Global Liraglutide Sales by Region: 2019-2024
3.2.2 Global Liraglutide Sales by Region: 2025-2030
3.3 Global Liraglutide Global Liraglutide Revenue by Region: 2019-2030
3.3.1 Global Liraglutide Revenue by Region: 2019-2024
3.3.2 Global Liraglutide Revenue by Region: 2025-2030
3.4 North America Liraglutide Market Facts & Figures by Country
3.4.1 North America Liraglutide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Liraglutide Sales by Country (2019-2030)
3.4.3 North America Liraglutide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liraglutide Market Facts & Figures by Country
3.5.1 Europe Liraglutide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Liraglutide Sales by Country (2019-2030)
3.5.3 Europe Liraglutide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liraglutide Market Facts & Figures by Country
3.6.1 Asia Pacific Liraglutide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Liraglutide Sales by Country (2019-2030)
3.6.3 Asia Pacific Liraglutide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liraglutide Market Facts & Figures by Country
3.7.1 Latin America Liraglutide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Liraglutide Sales by Country (2019-2030)
3.7.3 Latin America Liraglutide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liraglutide Market Facts & Figures by Country
3.8.1 Middle East and Africa Liraglutide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Liraglutide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Liraglutide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liraglutide Sales by Type (2019-2030)
4.1.1 Global Liraglutide Sales by Type (2019-2024)
4.1.2 Global Liraglutide Sales by Type (2025-2030)
4.1.3 Global Liraglutide Sales Market Share by Type (2019-2030)
4.2 Global Liraglutide Revenue by Type (2019-2030)
4.2.1 Global Liraglutide Revenue by Type (2019-2024)
4.2.2 Global Liraglutide Revenue by Type (2025-2030)
4.2.3 Global Liraglutide Revenue Market Share by Type (2019-2030)
4.3 Global Liraglutide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Liraglutide Sales by Application (2019-2030)
5.1.1 Global Liraglutide Sales by Application (2019-2024)
5.1.2 Global Liraglutide Sales by Application (2025-2030)
5.1.3 Global Liraglutide Sales Market Share by Application (2019-2030)
5.2 Global Liraglutide Revenue by Application (2019-2030)
5.2.1 Global Liraglutide Revenue by Application (2019-2024)
5.2.2 Global Liraglutide Revenue by Application (2025-2030)
5.2.3 Global Liraglutide Revenue Market Share by Application (2019-2030)
5.3 Global Liraglutide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 HEC Pharm
6.1.1 HEC Pharm Corporation Information
6.1.2 HEC Pharm Description and Business Overview
6.1.3 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 HEC Pharm Liraglutide Product Portfolio
6.1.5 HEC Pharm Recent Developments/Updates
6.2 Bachem
6.2.1 Bachem Corporation Information
6.2.2 Bachem Description and Business Overview
6.2.3 Bachem Liraglutide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bachem Liraglutide Product Portfolio
6.2.5 Bachem Recent Developments/Updates
6.3 Bharat Pharmaceuticals
6.3.1 Bharat Pharmaceuticals Corporation Information
6.3.2 Bharat Pharmaceuticals Description and Business Overview
6.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bharat Pharmaceuticals Liraglutide Product Portfolio
6.3.5 Bharat Pharmaceuticals Recent Developments/Updates
6.4 Kingpep Biotechnology
6.4.1 Kingpep Biotechnology Corporation Information
6.4.2 Kingpep Biotechnology Description and Business Overview
6.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kingpep Biotechnology Liraglutide Product Portfolio
6.4.5 Kingpep Biotechnology Recent Developments/Updates
6.5 Shenzhen JYMed Technology
6.5.1 Shenzhen JYMed Technology Corporation Information
6.5.2 Shenzhen JYMed Technology Description and Business Overview
6.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shenzhen JYMed Technology Liraglutide Product Portfolio
6.5.5 Shenzhen JYMed Technology Recent Developments/Updates
6.6 Wuxi Asiapeptide
6.6.1 Wuxi Asiapeptide Corporation Information
6.6.2 Wuxi Asiapeptide Description and Business Overview
6.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wuxi Asiapeptide Liraglutide Product Portfolio
6.6.5 Wuxi Asiapeptide Recent Developments/Updates
6.7 AmbioPharm
6.6.1 AmbioPharm Corporation Information
6.6.2 AmbioPharm Description and Business Overview
6.6.3 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AmbioPharm Liraglutide Product Portfolio
6.7.5 AmbioPharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liraglutide Industry Chain Analysis
7.2 Liraglutide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liraglutide Production Mode & Process
7.4 Liraglutide Sales and Marketing
7.4.1 Liraglutide Sales Channels
7.4.2 Liraglutide Distributors
7.5 Liraglutide Customers
8 Liraglutide Market Dynamics
8.1 Liraglutide Industry Trends
8.2 Liraglutide Market Drivers
8.3 Liraglutide Market Challenges
8.4 Liraglutide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
List of Tables
    Table 1. Global Liraglutide Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Liraglutide Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Liraglutide Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Liraglutide Sales (K MT) of Key Manufacturers (2019-2024)
    Table 5. Global Liraglutide Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Liraglutide Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Liraglutide Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Liraglutide Average Price (USD/MT) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Liraglutide, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Liraglutide, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Liraglutide, Product Type & Application
    Table 12. Global Key Manufacturers of Liraglutide, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Liraglutide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Liraglutide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Liraglutide Sales by Region (2019-2024) & (K MT)
    Table 18. Global Liraglutide Sales Market Share by Region (2019-2024)
    Table 19. Global Liraglutide Sales by Region (2025-2030) & (K MT)
    Table 20. Global Liraglutide Sales Market Share by Region (2025-2030)
    Table 21. Global Liraglutide Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Liraglutide Revenue Market Share by Region (2019-2024)
    Table 23. Global Liraglutide Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Liraglutide Revenue Market Share by Region (2025-2030)
    Table 25. North America Liraglutide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Liraglutide Sales by Country (2019-2024) & (K MT)
    Table 27. North America Liraglutide Sales by Country (2025-2030) & (K MT)
    Table 28. North America Liraglutide Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Liraglutide Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Liraglutide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Liraglutide Sales by Country (2019-2024) & (K MT)
    Table 32. Europe Liraglutide Sales by Country (2025-2030) & (K MT)
    Table 33. Europe Liraglutide Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Liraglutide Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Liraglutide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Liraglutide Sales by Region (2019-2024) & (K MT)
    Table 37. Asia Pacific Liraglutide Sales by Region (2025-2030) & (K MT)
    Table 38. Asia Pacific Liraglutide Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Liraglutide Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Liraglutide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Liraglutide Sales by Country (2019-2024) & (K MT)
    Table 42. Latin America Liraglutide Sales by Country (2025-2030) & (K MT)
    Table 43. Latin America Liraglutide Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Liraglutide Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Liraglutide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Liraglutide Sales by Country (2019-2024) & (K MT)
    Table 47. Middle East & Africa Liraglutide Sales by Country (2025-2030) & (K MT)
    Table 48. Middle East & Africa Liraglutide Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Liraglutide Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Liraglutide Sales (K MT) by Type (2019-2024)
    Table 51. Global Liraglutide Sales (K MT) by Type (2025-2030)
    Table 52. Global Liraglutide Sales Market Share by Type (2019-2024)
    Table 53. Global Liraglutide Sales Market Share by Type (2025-2030)
    Table 54. Global Liraglutide Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Liraglutide Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Liraglutide Revenue Market Share by Type (2019-2024)
    Table 57. Global Liraglutide Revenue Market Share by Type (2025-2030)
    Table 58. Global Liraglutide Price (USD/MT) by Type (2019-2024)
    Table 59. Global Liraglutide Price (USD/MT) by Type (2025-2030)
    Table 60. Global Liraglutide Sales (K MT) by Application (2019-2024)
    Table 61. Global Liraglutide Sales (K MT) by Application (2025-2030)
    Table 62. Global Liraglutide Sales Market Share by Application (2019-2024)
    Table 63. Global Liraglutide Sales Market Share by Application (2025-2030)
    Table 64. Global Liraglutide Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Liraglutide Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Liraglutide Revenue Market Share by Application (2019-2024)
    Table 67. Global Liraglutide Revenue Market Share by Application (2025-2030)
    Table 68. Global Liraglutide Price (USD/MT) by Application (2019-2024)
    Table 69. Global Liraglutide Price (USD/MT) by Application (2025-2030)
    Table 70. HEC Pharm Corporation Information
    Table 71. HEC Pharm Description and Business Overview
    Table 72. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 73. HEC Pharm Liraglutide Product
    Table 74. HEC Pharm Recent Developments/Updates
    Table 75. Bachem Corporation Information
    Table 76. Bachem Description and Business Overview
    Table 77. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 78. Bachem Liraglutide Product
    Table 79. Bachem Recent Developments/Updates
    Table 80. Bharat Pharmaceuticals Corporation Information
    Table 81. Bharat Pharmaceuticals Description and Business Overview
    Table 82. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 83. Bharat Pharmaceuticals Liraglutide Product
    Table 84. Bharat Pharmaceuticals Recent Developments/Updates
    Table 85. Kingpep Biotechnology Corporation Information
    Table 86. Kingpep Biotechnology Description and Business Overview
    Table 87. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 88. Kingpep Biotechnology Liraglutide Product
    Table 89. Kingpep Biotechnology Recent Developments/Updates
    Table 90. Shenzhen JYMed Technology Corporation Information
    Table 91. Shenzhen JYMed Technology Description and Business Overview
    Table 92. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 93. Shenzhen JYMed Technology Liraglutide Product
    Table 94. Shenzhen JYMed Technology Recent Developments/Updates
    Table 95. Wuxi Asiapeptide Corporation Information
    Table 96. Wuxi Asiapeptide Description and Business Overview
    Table 97. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 98. Wuxi Asiapeptide Liraglutide Product
    Table 99. Wuxi Asiapeptide Recent Developments/Updates
    Table 100. AmbioPharm Corporation Information
    Table 101. AmbioPharm Description and Business Overview
    Table 102. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 103. AmbioPharm Liraglutide Product
    Table 104. AmbioPharm Recent Developments/Updates
    Table 105. Key Raw Materials Lists
    Table 106. Raw Materials Key Suppliers Lists
    Table 107. Liraglutide Distributors List
    Table 108. Liraglutide Customers List
    Table 109. Liraglutide Market Trends
    Table 110. Liraglutide Market Drivers
    Table 111. Liraglutide Market Challenges
    Table 112. Liraglutide Market Restraints
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Liraglutide
    Figure 2. Global Liraglutide Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Liraglutide Market Share by Type in 2023 & 2030
    Figure 4. Pills Product Picture
    Figure 5. Liquid Product Picture
    Figure 6. Global Liraglutide Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Liraglutide Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Drug Store
    Figure 10. Global Liraglutide Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Liraglutide Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Liraglutide Sales (2019-2030) & (K MT)
    Figure 13. Global Liraglutide Average Price (USD/MT) & (2019-2030)
    Figure 14. Liraglutide Report Years Considered
    Figure 15. Liraglutide Sales Share by Manufacturers in 2023
    Figure 16. Global Liraglutide Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Liraglutide Players: Market Share by Revenue in 2023
    Figure 18. Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Liraglutide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Liraglutide Sales Market Share by Country (2019-2030)
    Figure 21. North America Liraglutide Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Liraglutide Sales Market Share by Country (2019-2030)
    Figure 25. Europe Liraglutide Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Liraglutide Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Liraglutide Revenue Market Share by Region (2019-2030)
    Figure 33. China Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Liraglutide Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Liraglutide Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Liraglutide Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Liraglutide Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Liraglutide Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Liraglutide by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Liraglutide by Type (2019-2030)
    Figure 54. Global Liraglutide Price (USD/MT) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Liraglutide by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Liraglutide by Application (2019-2030)
    Figure 57. Global Liraglutide Price (USD/MT) by Application (2019-2030)
    Figure 58. Liraglutide Value Chain
    Figure 59. Liraglutide Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Clinical Data Management and Statistical Analysis Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E10402
Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Global Cancer Tumor Profiling Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6B2891
Tue Apr 02 00:00:00 UTC 2024

Add to Cart

Receptive Cell - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34N12630
Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Adipose Tissue Derived Stem Cell - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-8X13846
Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions